Dr Margaret D Wood, MD | |
218a Sunset Rd, Rowansom Dept. Of General Internal Medicine, Willingboro, NJ 08046-1110 | |
(609) 835-2900 | |
(856) 566-6906 |
Full Name | Dr Margaret D Wood |
---|---|
Gender | Female |
Speciality | Hospitalist |
Location | 218a Sunset Rd, Willingboro, New Jersey |
Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
Identifier | Type | State | Issuer |
---|---|---|---|
1336137223 | NPI | - | NPPES |
0012622790011 | Medicaid | PA | |
110186699 | Other | NJ | RR MCR PTAN |
7968604 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RC0000X | Internal Medicine - Cardiovascular Disease | MD042715E (Pennsylvania) | Secondary |
208M00000X | Hospitalist | 25MA06868200 (New Jersey) | Primary |
Mailing Address | Practice Location Address |
---|---|
Dr Margaret D Wood, MD 218a Sunset Rd, Rowansom Dept. Of General Internal Medicine, Willingboro, NJ 08046-1110 Ph: (609) 835-2900 | Dr Margaret D Wood, MD 218a Sunset Rd, Rowansom Dept. Of General Internal Medicine, Willingboro, NJ 08046-1110 Ph: (609) 835-2900 |
News Archive
The presence of increased body fat, and therefore higher levels of inflammatory substances in the blood, hinders the loss and maintenance of body weight; as shown by a research project of the University of Navarra conducted by EstÃbaliz Goyenechea Soto, a scientist at the School of Pharmacy.
A new study, presented today at the Society of NeuroInterventional Surgery's 16th Annual Meeting, found that non-internal carotid artery site of occlusion, the use of a balloon-guided catheter, and better collateral grade were all independent predictors of the first pass effect.
About one in eight women in the United States will contract breast cancer in her lifetime. Now new research from Tel Aviv University-affiliated researchers, in collaboration with Johns Hopkins University, has provided another tool to help women, clinicians, and scientists searching for a cure to the one of the most widespread yet incurable diseases on the planet.
ARYx Therapeutics, Inc. today provided further clarification of its status as an operating company, including the on-going appointment of its officers on behalf of the Company. The NASDAQ Staff has requested additional clarification about the Company's operations in conjunction with their on-going consideration of the Company's eligibility for continued listing on The NASDAQ Capital Market.
Scientists at St. Jude Children's Research Hospital have identified inherited variations in two genes that account for 37 percent of childhood acute lymphoblastic leukemia (ALL), including a gene that may help predict drug response.
› Verified 5 days ago
Leah Asman, D.O. Hospitalist Medicare: Accepting Medicare Assignments Practice Location: 218 Sunset Rd Fl 5, Willingboro, NJ 08046 Phone: 609-835-3672 Fax: 609-835-5433 |